Skip to main content
Fig. 6 | Journal of Translational Medicine

Fig. 6

From: A novel approach for the co-delivery of 5-fluorouracil and everolimus for breast cancer combination therapy: stimuli-responsive chitosan hydrogel embedded with mesoporous silica nanoparticles

Fig. 6

In vivo evaluation of the nanosystem in a BALB/c mouse breast cancer model. (a) Body weight changes and (b) Tumor volume changes in mice during and after the treatment period. (c) Tumor growth inhibition efficiency for each treatment group. (d) Number of mice with lung metastases in each group after treatment. * P < 0.05, ** P < 0.01, *** P < 0.001 (n = 8)

Back to article page